Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus

Fuqiang Liu,1– 4 Feng Han,4,5 Xiaoli Liu,4,5 Lina Yang,4,5 Caixia Jiang,4,5 Chen Cui,1– 4 Fang Yuan,1– 4 Xin Zhang,1– 4 Lei Gong,1– 4 Xinguo Hou,1– 4 Yuan Liu,1– 4 Li Chen1– 4 1Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 2In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu F, Han F, Liu X, Yang L, Jiang C, Cui C, Yuan F, Zhang X, Gong L, Hou X, Liu Y, Chen L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/5f1921f454cc48c3b7194756c9936927
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f1921f454cc48c3b7194756c9936927
record_format dspace
spelling oai:doaj.org-article:5f1921f454cc48c3b7194756c99369272021-12-02T18:07:54ZCross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus1178-7007https://doaj.org/article/5f1921f454cc48c3b7194756c99369272021-10-01T00:00:00Zhttps://www.dovepress.com/cross-sectional-analysis-of-the-involvement-of-interleukin-17a-in-diab-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Fuqiang Liu,1– 4 Feng Han,4,5 Xiaoli Liu,4,5 Lina Yang,4,5 Caixia Jiang,4,5 Chen Cui,1– 4 Fang Yuan,1– 4 Xin Zhang,1– 4 Lei Gong,1– 4 Xinguo Hou,1– 4 Yuan Liu,1– 4 Li Chen1– 4 1Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 2Institute of Endocrine and Metabolic Diseases of Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 3Key Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, Shandong, 250012, People’s Republic of China; 4Jinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, Shandong, 250012, People’s Republic of China; 5Department of Endocrinology, Zhangqiu District People’s Hospital, Jinan, 250200, People’s Republic of ChinaCorrespondence: Yuan Liu; Li Chen Email liuyuan198735@163.com; chenli3@medmail.com.cnBackground: To investigate the correlation between serum interleukin-17A (IL-17A) levels and diabetic retinopathy (DR) in elderly individuals with type 2 diabetes mellitus (T2DM).Methods: The study included 194 elderly patients (94 males and 100 females) with T2DM. Digital retinal photography as well as fundus fluorescein angiography was employed to distinguish between nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). In addition, multiple logistic regression analysis was conducted to determine the correlation between serum IL-17A levels and DR status.Results: The average age of the study cohort was 69.14 ± 6.33 years, of which 52.08% were male. The study participants with the highest IL-17A (Q4) levels had higher TC, DBP, and low-density lipoprotein cholesterol (LDL-C) values than those the other groups. Analysis using unadjusted and adjusted linear regression revealed that the effect size of 1.09 for DR in the unadjusted model indicates that IL-17A is associated with an increase of 1.09 in DR (mmol/L) (β 1.09, 95% confidence interval (CI) 1.03, 1.16). Using the minimum-adjusted model (the model 2), as IL-17A increased, DR was higher by 1.11 (β 1.11, 95% CI 1.04, 1.18). With the fully adjusted model (the model 3), for each additional IL-17A increase, DR was higher by 1.15 (β 1.15, 95% CI 1.06, 1.24).Conclusion: Serum IL-17A levels are apparently positively correlated to DR in Chinese elderly individuals with T2DM.Keywords: interleukin-17A, diabetic retinopathy, type 2 diabetes mellitusLiu FHan FLiu XYang LJiang CCui CYuan FZhang XGong LHou XLiu YChen LDove Medical Pressarticleinterleukin-17adiabetic retinopathytype 2 diabetes mellitusSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 4199-4207 (2021)
institution DOAJ
collection DOAJ
language EN
topic interleukin-17a
diabetic retinopathy
type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
spellingShingle interleukin-17a
diabetic retinopathy
type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
Liu F
Han F
Liu X
Yang L
Jiang C
Cui C
Yuan F
Zhang X
Gong L
Hou X
Liu Y
Chen L
Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
description Fuqiang Liu,1– 4 Feng Han,4,5 Xiaoli Liu,4,5 Lina Yang,4,5 Caixia Jiang,4,5 Chen Cui,1– 4 Fang Yuan,1– 4 Xin Zhang,1– 4 Lei Gong,1– 4 Xinguo Hou,1– 4 Yuan Liu,1– 4 Li Chen1– 4 1Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 2Institute of Endocrine and Metabolic Diseases of Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 3Key Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, Shandong, 250012, People’s Republic of China; 4Jinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, Shandong, 250012, People’s Republic of China; 5Department of Endocrinology, Zhangqiu District People’s Hospital, Jinan, 250200, People’s Republic of ChinaCorrespondence: Yuan Liu; Li Chen Email liuyuan198735@163.com; chenli3@medmail.com.cnBackground: To investigate the correlation between serum interleukin-17A (IL-17A) levels and diabetic retinopathy (DR) in elderly individuals with type 2 diabetes mellitus (T2DM).Methods: The study included 194 elderly patients (94 males and 100 females) with T2DM. Digital retinal photography as well as fundus fluorescein angiography was employed to distinguish between nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). In addition, multiple logistic regression analysis was conducted to determine the correlation between serum IL-17A levels and DR status.Results: The average age of the study cohort was 69.14 ± 6.33 years, of which 52.08% were male. The study participants with the highest IL-17A (Q4) levels had higher TC, DBP, and low-density lipoprotein cholesterol (LDL-C) values than those the other groups. Analysis using unadjusted and adjusted linear regression revealed that the effect size of 1.09 for DR in the unadjusted model indicates that IL-17A is associated with an increase of 1.09 in DR (mmol/L) (β 1.09, 95% confidence interval (CI) 1.03, 1.16). Using the minimum-adjusted model (the model 2), as IL-17A increased, DR was higher by 1.11 (β 1.11, 95% CI 1.04, 1.18). With the fully adjusted model (the model 3), for each additional IL-17A increase, DR was higher by 1.15 (β 1.15, 95% CI 1.06, 1.24).Conclusion: Serum IL-17A levels are apparently positively correlated to DR in Chinese elderly individuals with T2DM.Keywords: interleukin-17A, diabetic retinopathy, type 2 diabetes mellitus
format article
author Liu F
Han F
Liu X
Yang L
Jiang C
Cui C
Yuan F
Zhang X
Gong L
Hou X
Liu Y
Chen L
author_facet Liu F
Han F
Liu X
Yang L
Jiang C
Cui C
Yuan F
Zhang X
Gong L
Hou X
Liu Y
Chen L
author_sort Liu F
title Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
title_short Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
title_full Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
title_fullStr Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
title_full_unstemmed Cross-Sectional Analysis of the Involvement of Interleukin-17A in Diabetic Retinopathy in Elderly Individuals with Type 2 Diabetes Mellitus
title_sort cross-sectional analysis of the involvement of interleukin-17a in diabetic retinopathy in elderly individuals with type 2 diabetes mellitus
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/5f1921f454cc48c3b7194756c9936927
work_keys_str_mv AT liuf crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT hanf crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT liux crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT yangl crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT jiangc crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT cuic crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT yuanf crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT zhangx crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT gongl crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT houx crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT liuy crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
AT chenl crosssectionalanalysisoftheinvolvementofinterleukin17aindiabeticretinopathyinelderlyindividualswithtype2diabetesmellitus
_version_ 1718378631001014272